ascendis transcon glp-1 program Novo pens $285M biobucks deal to use Ascendis' tech to create monthly agonist Novo Nordisk taps Ascendis in
Description
However, researchers have been increasingly interested in their use for chronic weight management
IN CASE YOU MISSED IT You could be one of 20 people to get a years worth of free Raising Canes chicken Extreme Rush set to open in April, bringing world-class fun to Pocatello Mountain America Center names Aaron White as new general manager Ticket holders for upcoming Spud Kings game can help kids and have a chance to win prizes If you have a Biz Buzz item you want to share, send it to [email protected]
Comparative efficacy and safety of glucagon-like peptide-1 receptor agonists in children and adolescents with obesity or overweight: a systematic review and network meta-analysis
Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response
